Increased Glomerular and Tubular Expression of Transforming Growth Factor-β1, Its Type II Receptor, and Activation of the Smad Signaling Pathway in the db/db Mouse

[1]  S. Hong,et al.  Extracellular signal-regulated kinase mediates stimulation of TGF-beta1 and matrix by high glucose in mesangial cells. , 2000, Journal of the American Society of Nephrology : JASN.

[2]  K. Sharma,et al.  Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. Varga,et al.  Interaction of Smad3 with a proximal smad‐binding element of the human α2(I) procollagen gene promoter required for transcriptional activation by TGF‐β , 2000 .

[4]  M. Isono,et al.  Stimulation of TGF-beta type II receptor by high glucose in mouse mesangial cells and in diabetic kidney. , 2000, American journal of physiology. Renal physiology.

[5]  J. Massagué,et al.  Transcriptional control by the TGF‐β/Smad signaling system , 2000 .

[6]  G. King,et al.  Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC β inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  H. Schnaper,et al.  The transforming growth factor-βbgr/SMAD signaling pathway is present and functional in human mesangial cells , 1999 .

[8]  D. C. Han,et al.  High glucose stimulates proliferation and collagen type I synthesis in renal cortical fibroblasts: mediation by autocrine activation of TGF-beta. , 1999, Journal of the American Society of Nephrology : JASN.

[9]  J. Yee,et al.  TGF-beta receptor expression and binding in rat mesangial cells: modulation by glucose and cyclic mechanical strain. , 1999, Kidney international.

[10]  Z. Makita,et al.  Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195 , 1999, Diabetologia.

[11]  S. Tashiro,et al.  ATF-2 Is a Common Nuclear Target of Smad and TAK1 Pathways in Transforming Growth Factor-β Signaling* , 1999, The Journal of Biological Chemistry.

[12]  R. Derynck,et al.  Transcriptional Activators of TGF-β Responses: Smads , 1998, Cell.

[13]  K. Sharma,et al.  Transcriptional activation of transforming growth factor-beta1 in mesangial cell culture by high glucose concentration. , 1998, Kidney international.

[14]  R. Derynck,et al.  Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription , 1998, Nature.

[15]  Denis Vivien,et al.  Direct binding of Smad3 and Smad4 to critical TGFβ‐inducible elements in the promoter of human plasminogen activator inhibitor‐type 1 gene , 1998, The EMBO journal.

[16]  Jia Guo,et al.  The Renal TGF-β System in the db/db Mouse Model of Diabetic Nephropathy , 1998, Nephron Experimental Nephrology.

[17]  K. Kinzler,et al.  Human Smad3 and Smad4 are sequence-specific transcription activators. , 1998, Molecular cell.

[18]  Kohei Miyazono,et al.  TGF-β signalling from cell membrane to nucleus through SMAD proteins , 1997, Nature.

[19]  K. Sharma,et al.  Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy. , 1997, Seminars in nephrology.

[20]  H. Abboud,et al.  Expression of Transforming Growth Factor-β and Type IV Collagen in Early Streptozotocin-Induced Diabetes , 1997, Diabetes.

[21]  C. Chang,et al.  Captopril reverses high-glucose-induced growth effects on LLC-PK1 cells partly by decreasing transforming growth factor-beta receptor protein expressions. , 1996, Journal of the American Society of Nephrology : JASN.

[22]  M. Daha,et al.  Effects of high glucose on the production of heparan sulfate proteoglycan by mesangial and epithelial cells. , 1996, Kidney international.

[23]  Y. Akai,et al.  Quantification of glomerular TGF-β1 mRNA in patients with diabetes mellitus , 1996 .

[24]  Jia Guo,et al.  Neutralization of TGF-β by Anti-TGF-β Antibody Attenuates Kidney Hypertrophy and the Enhanced Extracellular Matrix Gene Expression in STZ-Induced Diabetic Mice , 1996, Diabetes.

[25]  L. Tartaglia,et al.  Evidence That the Diabetes Gene Encodes the Leptin Receptor: Identification of a Mutation in the Leptin Receptor Gene in db/db Mice , 1996, Cell.

[26]  C. Nast,et al.  Expression of transforming growth factor-β isoforms in human glomerular diseases , 1996 .

[27]  F N Ziyadeh,et al.  Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy. , 1995, The Journal of clinical investigation.

[28]  K. Sharma,et al.  Renal hypertrophy is associated with upregulation of TGF-beta 1 gene expression in diabetic BB rat and NOD mouse. , 1994, The American journal of physiology.

[29]  K. Thai,et al.  Expression of transforming growth factor-β1 during diabetic renal hypertrophy , 1994 .

[30]  K. Sharma,et al.  Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. , 1994, The Journal of clinical investigation.

[31]  E Ruoslahti,et al.  Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Yasuhiro Watanabe,et al.  In situ DNA-protein binding: A novel method for detecting DNA-binding activity of transcription factor in brain , 1992, Neuroscience Letters.

[33]  F. Ziyadeh,et al.  Hormones, autacoids, and the kidney , 1992 .

[34]  R. Weinberg,et al.  Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase , 1992, Cell.

[35]  T. Haverty,et al.  Role of insulin and IGF1 receptors in proliferation of cultured renal proximal tubule cells. , 1992, Biochimica et biophysica acta.

[36]  S. Lee,et al.  Early immunopathologic events in experimental diabetic nephropathy: a study in db/db mice. , 1980, Experimental and molecular pathology.

[37]  W. Chick,et al.  Studies in the diabetic mutant mouse. VI. Evolution of glomerular lesions and associated proteinuria. , 1972, The American journal of pathology.

[38]  S. J. Chen,et al.  Interaction of smad3 with a proximal smad-binding element of the human alpha2(I) procollagen gene promoter required for transcriptional activation by TGF-beta. , 2000, Journal of cellular physiology.

[39]  J. Egido,et al.  In situ non-radioactive detection of nuclear factors in paraffin sections by Southwestern histochemistry. , 1999, Kidney international.

[40]  R. Derynck,et al.  Smads: transcriptional activators of TGF-beta responses. , 1998, Cell.

[41]  H. Abboud,et al.  Erratum: Expression of transforming growth factor-β and type IV collagen in early streptozotocin-induced diabetes (Diabetes (1997) 46 (473- 480)) , 1997 .

[42]  Y. Akai,et al.  Quantification of glomerular TGF-beta 1 mRNA in patients with diabetes mellitus. , 1996, Kidney international.

[43]  M. Rocco,et al.  Elevated glucose stimulates TGF-beta gene expression and bioactivity in proximal tubule. , 1992, Kidney international.